Indegene has announced the sixth edition of Indegene Digital Summit, one of the most anticipated events for pharma leaders across the world, on October 17 and 18, 2024.

The virtual summit brings together senior pharma executives and tech innovators to discuss strategies and best practices to make the pharma industry future-ready.

This year’s edition offers practitioners' perspectives on key topics such as Generative AI, Advanced Analytics, Technology Transformation and Operations Transformation.

With no vendors or booths, the summit continues to facilitate an open exchange of ideas, foster collaboration, and promote thought leadership.

Keynote speakers include renowned pharma CXOs include, Olivier Charmeil, EVP, General Medicines, Sanofi; Emmanuel Caeymaex, Chief Commercial Officer, UCB; Adele M. Gulfo, CEO, Biopharma Commercial Unit, Sumitomo Pharma America, Inc; Suneet Varma, Global Oncology & US President, Pfizer; Alok Sonig, EVP and Group President, Pharmaceuticals, Baxter; Dave Lennon, President and CEO, Aadi Bioscience

“In a GenAI world, pharma commercialization leaders are at crossroads, navigating important decisions in processes and technology to build resilient, future-ready organizations,” said Gaurav Kapoor, Executive Vice President of Indegene.

“This year, Indegene Digital Summit brings together pharma and digital experts to enable the industry to cut through the noise and chart a transformative path with a multi-decadal perspective,” added Kapoor.